Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/8/2022
FDA Changes Tune On China-Developed Drugs as Lilly and Innovent Draws ...
2/8/2022
'I Have A Right to Change My Mind': A Top FDA Regulator Is Unapologeti...
2/7/2022
Why Chinese Drugmakers Fail to Reach for the STAR (PharmaDJ)
2/7/2022
FDA Says It Had No Input as Companies Developed Checkpoint Inhibitors ...
2/7/2022
Mybio Publishes the 2021 China Pharma BD Transactions Report
2/7/2022
Aurealis and Xbiome Entered a License Deal for AUP-16 Cell/Gene The...
2/7/2022
U.S. Adds Wuxi Biologics to 'Unverified List'
2/7/2022
MIIT: China to Beef Up Anti-monopoly Efforts in Pharma Industry
2/7/2022
Pfizer Sues Two Ex-employees for Trade Secret Theft, Implicating Qilu ...
1/30/2022
China Issues the 14th Five Year Plan for Pharmaceutical Industry Devel...
1/30/2022
NHSA Issues the Interim Measures for Handling Tips Related to Supervis...
1/30/2022
Recent Executive Moves
1/30/2022
Drug R&D and Product Registration News Digest January 2022 (4)
1/30/2022
Financial-related Company News Digest
1/30/2022
NRDL, NEDL and the Latest Ups and Downs of Chinese Pharma amid Uncerta...
1/29/2022
CDE Issues the Technical Guidelines for Clinical Risk Management Plan ...
1/29/2022
NHC Solicits Comments on the Interim Measures for Human Biological Sam...
1/29/2022
NHSA Publicizes Scandal of Basic Medical Insurance Frauds Involving As...
1/28/2022
NMPA Holds the National Drug Registration Control and Drug Post-Market...
1/28/2022
NHC Holds the 2022 National Health Working Conference
1/28/2022
NMPA Suspends Import, Sales and Use of JWLS's Fat Emulsion Product in ...
1/27/2022
CDE Publicizes the List of Reference Formulations for GQCE Studies (55...
1/27/2022
CDE Issues the Technical Guidance on Clinical Protocol for Liraglutide...
1/27/2022
CDE Issues the Guidelines for Clinical Trial Protocol Design for Once ...
1/26/2022
NMPA Announces Package Insert Revision of Numerous Drug Products
1/26/2022
93 Listed MedPharm Cos Release 2021 Performance Guidance amid Weakness
1/26/2022
China Designates Shenzhen as Pilot Zone for Improved Market Access wit...
1/26/2022
Information Collection on the 7th VBP Initiated at Numerous Provinces
1/26/2022
BfV Warns German Pharma and Tech Firms About Being Targeted by Hacker...
1/26/2022
New Drug Approvals in 2021: 64 New Molecular Entities, 24 from Local P...
Page:
95
/
719
Total number of articles:
21546
:
[First]
[<<]
[93]
[94]
[95]
[96]
[97]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit